Analystreport

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is now covered by analysts at Evercore ISI. They set a $143.00 price target on the stock.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview